Page last updated: 2024-08-23

selegiline and Central Nervous System Origin Vertigo

selegiline has been researched along with Central Nervous System Origin Vertigo in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kraus, L; Rujescu, D; Schautzer, F; Strupp, M	1

Other Studies

1 other study(ies) available for selegiline and Central Nervous System Origin Vertigo

Article	Year
Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study. Journal of neurology, 2018, Volume: 265, Issue:Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Betahistine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Meniere Disease; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Vasodilator Agents; Vertigo	2018

Article

Year

Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.

Journal of neurology, 2018, Volume: 265, Issue:Suppl 1

Topics: Adult; Aged; Aged, 80 and over; Betahistine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Meniere Disease; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Vasodilator Agents; Vertigo

2018